NCT02035371View on ClinicalTrials.gov

A Trial Investigating the Pharmacokinetic Properties of FIAsp in Children, Adolescents and Adults With Type 1 Diabetes

PHASE1CompletedINTERVENTIONAL
Enrollment

41

Participants

Timeline

Start Date

January 13, 2014

Primary Completion Date

July 24, 2014

Study Completion Date

July 24, 2014

Conditions
DiabetesDiabetes Mellitus, Type 1
Interventions
DRUG

Faster-acting insulin aspart

A single dose will be administered subcutaneously (s.c. under the skin)

DRUG

insulin aspart

A single dose will be administered subcutaneously (s.c. under the skin)

Trial Locations (1)

30173

Novo Nordisk Investigational Site, Hanover

Sponsors

Lead Sponsor

Novo Nordisk A/S
All Listed Sponsors
lead

Novo Nordisk A/S

INDUSTRY